Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris

Saved in:
Bibliographic Details
Published in:Journal of the European Academy of Dermatology and Venereology 2022-10, Vol.36 (10), p.852-855
Main Authors: Murrell, D.F., Patsatsi, A., Stavropoulos, P., Baum, S., Zeeli, T., Kern, J.S., Sinclair, R., Neale, A., Arora, P., Sugerman, P.B., Shi, G., Werth, V.P., Caux, F., Joly, P., Stavropolous, P.
Format: Article
Language:English
Subjects:
bullous disorders
disease control
pemphigus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.18318